Cargando…

Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB

Recent studies have suggested that transplant of hiPS-CMs is a promising approach for treating heart failure. However, the optimally clinical benefits have been hampered by the immature nature of the hiPS-CMs, and the hiPS-CMs-secreted proteins contributing to the repair of cardiomyocytes remain lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongmei, Wu, Fenfang, Huang, Guangrui, Wu, Di, Wang, Ting, Wang, Xiashuang, Wang, Kai, Feng, Yuyin, Xu, Anlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334380/
https://www.ncbi.nlm.nih.gov/pubmed/35902567
http://dx.doi.org/10.1038/s41392-022-01045-4
_version_ 1784759092595654656
author Li, Hongmei
Wu, Fenfang
Huang, Guangrui
Wu, Di
Wang, Ting
Wang, Xiashuang
Wang, Kai
Feng, Yuyin
Xu, Anlong
author_facet Li, Hongmei
Wu, Fenfang
Huang, Guangrui
Wu, Di
Wang, Ting
Wang, Xiashuang
Wang, Kai
Feng, Yuyin
Xu, Anlong
author_sort Li, Hongmei
collection PubMed
description Recent studies have suggested that transplant of hiPS-CMs is a promising approach for treating heart failure. However, the optimally clinical benefits have been hampered by the immature nature of the hiPS-CMs, and the hiPS-CMs-secreted proteins contributing to the repair of cardiomyocytes remain largely unidentified. Here, we established a saponin(+) compound optimally induced system to generate hiPS-CMs with stable functional attributes in vitro and transplanted in heart failure mice. Our study showed enhanced therapeutic effects of optimally induced hiPS-CMs by attenuating cardiac remodeling and dysfunction, these beneficial effects were concomitant with reduced cardiomyocytes death and increased angiogenesis. Moreover, the optimally induced hiPS-CMs could gathering to the injured heart and secret an abundant PDGF-BB. The reparative effect of the optimally induced hiPS-CMs in the hypoxia-injured HCMs was mimicked by PDGF-BB but inhibited by PDGF-BB neutralizing antibody, which was accompanied by the changed expression of p-PI3K and p-Akt proteins. It is highly possible that the PI3K/Akt pathway is regulated by the PDGF-BB secreted from the compound induced hiPS-CMs to achieve a longer lasting myocardial repair effect compared with the standard induced hiPS-CMs. Taken together, our data strongly implicate that the compound induced hiPS-CMs promote the recovery of injured hearts via paracrine action. In this process, the paracrine factor PDGF-BB derived from the compound induced hiPS-CMs reduces isoproterenol-induced adverse cardiac remodeling, which is associated with improved cardiac function, and these effects are mediated by the PI3K/Akt pathway, suggesting that the optimally induced hiPS-CMs may serve as a new promising cell therapy for clinical applications.
format Online
Article
Text
id pubmed-9334380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93343802022-07-30 Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB Li, Hongmei Wu, Fenfang Huang, Guangrui Wu, Di Wang, Ting Wang, Xiashuang Wang, Kai Feng, Yuyin Xu, Anlong Signal Transduct Target Ther Article Recent studies have suggested that transplant of hiPS-CMs is a promising approach for treating heart failure. However, the optimally clinical benefits have been hampered by the immature nature of the hiPS-CMs, and the hiPS-CMs-secreted proteins contributing to the repair of cardiomyocytes remain largely unidentified. Here, we established a saponin(+) compound optimally induced system to generate hiPS-CMs with stable functional attributes in vitro and transplanted in heart failure mice. Our study showed enhanced therapeutic effects of optimally induced hiPS-CMs by attenuating cardiac remodeling and dysfunction, these beneficial effects were concomitant with reduced cardiomyocytes death and increased angiogenesis. Moreover, the optimally induced hiPS-CMs could gathering to the injured heart and secret an abundant PDGF-BB. The reparative effect of the optimally induced hiPS-CMs in the hypoxia-injured HCMs was mimicked by PDGF-BB but inhibited by PDGF-BB neutralizing antibody, which was accompanied by the changed expression of p-PI3K and p-Akt proteins. It is highly possible that the PI3K/Akt pathway is regulated by the PDGF-BB secreted from the compound induced hiPS-CMs to achieve a longer lasting myocardial repair effect compared with the standard induced hiPS-CMs. Taken together, our data strongly implicate that the compound induced hiPS-CMs promote the recovery of injured hearts via paracrine action. In this process, the paracrine factor PDGF-BB derived from the compound induced hiPS-CMs reduces isoproterenol-induced adverse cardiac remodeling, which is associated with improved cardiac function, and these effects are mediated by the PI3K/Akt pathway, suggesting that the optimally induced hiPS-CMs may serve as a new promising cell therapy for clinical applications. Nature Publishing Group UK 2022-07-29 /pmc/articles/PMC9334380/ /pubmed/35902567 http://dx.doi.org/10.1038/s41392-022-01045-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, Hongmei
Wu, Fenfang
Huang, Guangrui
Wu, Di
Wang, Ting
Wang, Xiashuang
Wang, Kai
Feng, Yuyin
Xu, Anlong
Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title_full Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title_fullStr Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title_full_unstemmed Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title_short Cardiomyocytes induced from hiPSCs by well-defined compounds have therapeutic potential in heart failure by secreting PDGF-BB
title_sort cardiomyocytes induced from hipscs by well-defined compounds have therapeutic potential in heart failure by secreting pdgf-bb
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334380/
https://www.ncbi.nlm.nih.gov/pubmed/35902567
http://dx.doi.org/10.1038/s41392-022-01045-4
work_keys_str_mv AT lihongmei cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT wufenfang cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT huangguangrui cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT wudi cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT wangting cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT wangxiashuang cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT wangkai cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT fengyuyin cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb
AT xuanlong cardiomyocytesinducedfromhipscsbywelldefinedcompoundshavetherapeuticpotentialinheartfailurebysecretingpdgfbb